Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription


6 Alzheimers Dement
1 BMC Geriatr
4 J Alzheimers Dis
3 J Am Geriatr Soc
2 Neurobiol Aging
2 Neurobiol Dis
1 Neurochem Res
7 Neurology
1 Neurosci Lett
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Alzheimers Dement

  1. WEINER MW, Veitch DP, Miller MJ, Aisen PS, et al
    Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.
    Alzheimers Dement. 2022 Oct 9. doi: 10.1002/alz.12797.
    PubMed         Abstract available

  2. DEPYPERE H, Vergallo A, Lemercier P, Lista S, et al
    Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease.
    Alzheimers Dement. 2022 Sep 15. doi: 10.1002/alz.12759.
    PubMed         Abstract available

  3. LIEBERMAN OJ, Lee S, Zabinski J
    Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium.
    Alzheimers Dement. 2022 Oct 11. doi: 10.1002/alz.12807.
    PubMed         Abstract available

  4. HARERIMANA NV, Paliwali D, Romero-Molina C, Bennett DA, et al
    The role of mitochondrial genome abundance in Alzheimer's disease.
    Alzheimers Dement. 2022 Oct 12. doi: 10.1002/alz.12812.
    PubMed         Abstract available

  5. AAIC((R)) 2022: The promise of Alzheimer's research.
    Alzheimers Dement. 2022 Oct 12. doi: 10.1002/alz.12829.

  6. NILSSON J, Cousins KAQ, Gobom J, Portelius E, et al
    Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
    Alzheimers Dement. 2022 Oct 14. doi: 10.1002/alz.12809.
    PubMed         Abstract available

    BMC Geriatr

  7. FORNS J, Danysh HE, McQuay LJ, Turner ME, et al
    Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States.
    BMC Geriatr. 2022;22:784.
    PubMed         Abstract available

    J Alzheimers Dis

  8. FUKUDA H, Maeda M, Murata F, Murata Y, et al
    Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer's Disease Patients in Japan: LIFE Study.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220200. doi: 10.3233/JAD-220200.
    PubMed         Abstract available

  9. HUANG Y, Driedonks TAP, Cheng L, Rajapaksha H, et al
    Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220322. doi: 10.3233/JAD-220322.
    PubMed         Abstract available

  10. WELLER AE, Ferraro TN, Doyle GA, Reiner BC, et al
    Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220391. doi: 10.3233/JAD-220391.
    PubMed         Abstract available

  11. LI TR, Lyu DY, Liu FQ
    Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
    J Alzheimers Dis. 2022 Oct 6. pii: JAD220598. doi: 10.3233/JAD-220598.
    PubMed         Abstract available

    J Am Geriatr Soc

  12. GILSTRAP L, Cohen A, Ouellet GM, Goyal P, et al
    The association between beta-blockers and outcomes in patients with heart failure and concurrent Alzheimer's disease and related dementias.
    J Am Geriatr Soc. 2022 Oct 14. doi: 10.1111/jgs.18086.
    PubMed         Abstract available

  13. ZHENG X, Tang Y, Yang Q, Wang S, et al
    Effectiveness and safety of anti-tau drugs for Alzheimer's disease: Systematic review and meta-analysis.
    J Am Geriatr Soc. 2022 Oct 8. doi: 10.1111/jgs.18025.
    PubMed         Abstract available

  14. DEVI G
    Tolerability and safety with aducanumab in Alzheimer's disease in a community-based setting on a slower titration schedule.
    J Am Geriatr Soc. 2022 Oct 8. doi: 10.1111/jgs.18059.

    Neurobiol Aging

  15. PAULSEN AJ, Schubert CR, Pinto AA, Chappell RJ, et al
    Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer's disease in midlife.
    Neurobiol Aging. 2022;120:177-188.
    PubMed         Abstract available

  16. WU W, Yu J, Qian X, Wang X, et al
    Intermediate-length CGG repeat expansion in NOTCH2NLC is associated with pathologically confirmed Alzheimer's disease.
    Neurobiol Aging. 2022 Sep 17. pii: S0197-4580(22)00203.
    PubMed         Abstract available

    Neurobiol Dis

  17. LIN L, Petralia RS, Holtzclaw L, Wang YX, et al
    Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice.
    Neurobiol Dis. 2022 Oct 6:105887. doi: 10.1016/j.nbd.2022.105887.
    PubMed         Abstract available

  18. QUINN JF, Kelly MJ, Harris CJ, Hack W, et al
    The novel estrogen modulator STX attenuates Amyloid-beta neurotoxicity in the 5XFAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2022 Oct 6:105888. doi: 10.1016/j.nbd.2022.105888.
    PubMed         Abstract available

    Neurochem Res

  19. LIU M, Lian B, Lan Z, Sun H, et al
    Transcriptomic Profile Identifies Hippocampal Sgk1 as the Key Mediator of Ovarian Estrogenic Regulation on Spatial Learning and Memory and Abeta Accumulation.
    Neurochem Res. 2022;47:3369-3384.
    PubMed         Abstract available


  20. ZETTERBERG H, Schott JM
    Objectifying Subjective Cognitive Decline: The Prognostic Role of Alzheimer Biomarkers.
    Neurology. 2022 Sep 2. pii: WNL.0000000000201172.

  21. CROTTY GF, Keavney JL, Alcalay RN, Marek K, et al
    Planning for Prevention of Parkinson Disease: Now Is the Time.
    Neurology. 2022;99.
    PubMed         Abstract available

  22. GREENBERG BD, Pettigrew C, Soldan A, Wang J, et al
    CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and ApoE4.
    Neurology. 2022;99:e1640-e1650.
    PubMed         Abstract available

  23. PIAZZA F, Caminiti SP, Zedde M, Presotto L, et al
    Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-A Autoantibodies.
    Neurology. 2022 Aug 8. pii: WNL.0000000000200892.
    PubMed         Abstract available

  24. DUBBELMAN MA, Verrijp M, Terwee CB, Jutten RJ, et al
    Determining the Minimal Important Change of Everyday Functioning in Dementia: Pursuing Clinical Meaningfulness.
    Neurology. 2022;99:e954-e964.
    PubMed         Abstract available

  25. SUGDEN K, Caspi A, Elliott ML, Bourassa KJ, et al
    Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia.
    Neurology. 2022;99:e1402-e1413.
    PubMed         Abstract available

  26. DEMNITZ-KING H, Gonneaud J, Klimecki OM, Chocat A, et al
    Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults.
    Neurology. 2022;99:e1422-e1431.
    PubMed         Abstract available

    Neurosci Lett

  27. RAFIEY M, Nosrati R, Babaei P
    Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats.
    Neurosci Lett. 2022;789:136881.
    PubMed         Abstract available

    PLoS One

  28. SUGIOKA J, Suzumura S, Kuno K, Kizuka S, et al
    Relationship between finger movement characteristics and brain voxel-based morphometry.
    PLoS One. 2022;17:e0269351.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  29. WANG X, Rimal S, Tantray I, Geng J, et al
    Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2-encoded Nsp1.
    Proc Natl Acad Sci U S A. 2022;119:e2202322119.
    PubMed         Abstract available

    Rev Neurol

  30. POUDEVIDA S, de Sola S, Brugulat-Serrat A, Mas-Vall Llosera G, et al
    [Effectiveness of a psychotherapeutic intervention group program in the improvement of caregiver well-being in Alzheimer's disease patients' family caregivers: the CuiDem study].
    Rev Neurol. 2022;75:203-211.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.